Publicaciones (65) Publicaciones de Miguel Blanquer Blanquer

2024

  1. Flow Cytometry as a New Accessible Method to Evaluate Diagnostic Osmotic Changes in Patients with Red Blood Cell Membrane Defects

    Biomedicines, Vol. 12, Núm. 7

  2. Hematopoietic stem cell transplantation in children with chronic granulomatous disease: the Spanish experience

    Frontiers in Immunology, Vol. 15

  3. Heterogeneity of mesenchymal cells in human amniotic membrane at term

    Histology and histopathology, Vol. 39, Núm. 5, pp. 573-593

  4. Measurable residual disease study through three different methods can anticipate relapse and guide early interventions in childhood acute lymphoblastic leukemia

    Clinical and Translational Oncology, Vol. 26, Núm. 1, pp. 278-287

  5. Optimizing cryopreservation conditions for use of fucosylated human mesenchymal stromal cells in anti-inflammatory/immunomodulatory therapeutics

    Frontiers in Immunology, Vol. 15

  6. Real-world outcomes of tandem ASCT in newly diagnosed multiple myeloma patients with standard risk features: a single-center analysis

    Bone Marrow Transplantation

  7. The nuclei of human adult stem cells can move within the cell and generate cellular protrusions to contact other cells

    Stem cell research & therapy, Vol. 15, Núm. 1, pp. 32

2023

  1. Measurable residual disease study through three different methods can anticipate relapse and guide pre-emptive therapy in childhood acute myeloid leukemia

    Clinical and Translational Oncology, Vol. 25, Núm. 5, pp. 1446-1454

  2. N-Acetylcistein for thrombotic thrombocytopenic purpura: an observational case series study

    Annals of Hematology, Vol. 102, Núm. 8, pp. 2069-2075

  3. ZAKα/P38 kinase signaling pathway regulates hematopoiesis by activating the NLRP1 inflammasome

    EMBO Molecular Medicine, Vol. 15, Núm. 10

2022

  1. Binucleated human bone marrow-derived mesenchymal cells can be formed during neural-like differentiation with independence of any cell fusion events

    Scientific Reports, Vol. 12, Núm. 1

  2. Case Report: α-Spectrin Mutation Associated with αLELY Polymorphism Responsible for Hereditary Pyropoikilocytosis

    Hematology Reports, Vol. 14, Núm. 4, pp. 300-304

  3. Enforced mesenchymal stem cell tissue colonization counteracts immunopathology

    npj Regenerative Medicine, Vol. 7, Núm. 1

  4. New Insights Into Pathophysiology of β-Thalassemia

    Frontiers in Medicine, Vol. 9

2021

  1. Allogeneic hematopoietic stem cell transplant recipients in Spain: Human leukocyte antigen characteristics and diversity by high-resolution analysis

    HLA, Vol. 97, Núm. 3, pp. 198-213

  2. Phase 2 Clinical Trial of Infusing Haploidentical K562-mb15-41BBL–Activated and Expanded Natural Killer Cells as Consolidation Therapy for Pediatric Acute Myeloblastic Leukemia

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 21, Núm. 5, pp. 328-337.e1

  3. Predictive value of 1q21 gain in multiple myeloma is strongly dependent on concurrent cytogenetic abnormalities and first-line treatment

    AMERICAN JOURNAL OF CANCER RESEARCH, Vol. 11, Núm. 9, pp. 4438-4456

2020

  1. Agreements and uncertainties in autologous haematopoietic stem cell mobilization and collection. A Spanish consensus document

    Bone Marrow Transplantation, Vol. 55, Núm. 4, pp. 811-817

  2. Bone marrow-derived mononuclear cell transplants decrease retinal gliosis in two animal models of inherited photoreceptor degeneration

    International Journal of Molecular Sciences, Vol. 21, Núm. 19, pp. 1-21

  3. Defibrotide inhibits donor leucocyte-endothelial interactions and protects against acute graft-versus-host disease

    Journal of Cellular and Molecular Medicine, Vol. 24, Núm. 14, pp. 8031-8044